证券记录 · 已归档季度
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
26被追踪持有人
+1Δ持有人
120.93M持有股份
$47.35B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +4.0% ·
股份流向 -4.1% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.30M | $664.72M | n/a | n/a |
| Q2 2026 | 173 | -1 | 210.42M | $104.38B | +5 | −7 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | n/a | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | n/a |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | n/a | n/a |
| Q2 2024 | 19 | n/a | 46.47M | $21.77B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 25.91M | -9.8% | $10.15B | 1.4% | ▼ Trim | 6 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 24.22M | +1.0% | $9.48B | 0.1% | ▲ Add | 2 | SEC ↗ ×7 |
| 3 | BlackRock ✦ (被动) | 22.25M | +1.7% | $8.72B | 0.2% | ▲ Add | 2 | SEC ↗ ×22 |
| 4 | JPMorgan Chase ✦ | 12.87M | n/a | $5.04B | 0.2% | n/c | 1 | SEC ↗ ×44 |
| 5 | State Street Global Advisors ✦ (被动) | 11.61M | -1.4% | $4.55B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 5.97M | +0.8% | $2.33B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 4.77M | -0.9% | $1.87B | 0.3% | ▼ Trim | 6 | SEC ↗ ×8 |
| 8 | Fidelity (FMR) ✦ | 3.30M | -48.4% | $1.29B | 0.1% | ▼ Trim | 2 | SEC ↗ ×5 |
| 9 | Morgan Stanley ✦ | 3.11M | n/a | $1.22B | 0.1% | n/c | 1 | SEC ↗ ×21 |
| 10 | T. Rowe Price ✦ | 3.04M | -3.7% | $1.19B | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 11 | Goldman Sachs Group ✦ | 1.48M | n/a | $581.45M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 12 | Renaissance Technologies ✦ | 735.89K | -26.8% | $288.20M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 482.50K | +170.8% | $188.96M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 381.19K | +520.1% | $149.29M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 207.06K | -2.5% | $81.09M | 0.1% | ▼ Trim | 6 | SEC ↗ ×4 |
| 16 | Citadel Advisors ✦ | 173.50K | +501.9% | $67.95M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | AQR Capital Management ✦ | 161.68K | +14.2% | $63.32M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 18 | Marshall Wace ✦ | 45.88K | -60.8% | $17.97M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Millennium Management ✦ | 41.04K | 新增 | $16.07M | 0.0% | New | 1 | SEC ↗ |
| 20 | Tweedy, Browne ✦ | 39.06K | +4.9% | $15.30M | 1.3% | ▲ Add | 6 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 38.32K | +11.4% | $15.01M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 25.96K | +0.8% | $10.17M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | ARK Investment Management ✦ | 25.66K | +6.7% | $10.05M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 21.89K | +2.5% | $8.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 3.34K | -83.3% | $1.31M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 26 | GAMCO Investors ✦ | 512 | 0.0% | $200,520 | 0.0% | Held | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $16.07M | 0.0% |
已清仓
| Norges Bank | $1.59B | 曾为 0.2% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,678 持有人, 225.07M 股份, $98.10B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据